Enlivex Therapeutics
ENLV
ENLV
8 hedge funds and large institutions have $1.8M invested in Enlivex Therapeutics in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
Holders
8
Holders Change
+2
Holders Change %
+33.33%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
4
Increased
1
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Renaissance Technologies
New York
|
$1.38M |
| 2 |
2
Jane Street
New York
|
$155K |
| 3 |
3
Two Sigma Investments
New York
|
$56K |
| 4 |
4
Two Sigma Advisers
New York
|
$51K |
| 5 |
5
UBS Group
Zurich,
Switzerland
|
$2K |
Top Sellers
| 1 |
SM
1
Sabby Management
Miami Beach,
Florida
|
$65K |
| 2 |
CH
2
CVI Holdings
Wilmington,
Delaware
|
$93K |
| 3 |
3
Bank of Montreal
Toronto,
Ontario, Canada
|
$0 |
| 4 |
4
JPMorgan Chase & Co
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $1.38M | 271,706 | +176,716 | +186% |
|
|
2
Jane Street
New York
| $155K | 30,711 | +30,711 | New |
|
|
CH
3
CVI Holdings
Wilmington,
Delaware
| $93K | 18,464 | -367,157 | -95% |
|
|
SM
4
Sabby Management
Miami Beach,
Florida
| $65K | 12,925 | -432,748 | -97% |
|
|
5
Two Sigma Investments
New York
| $56K | 10,971 | +10,971 | New |
|
|
6
Two Sigma Advisers
New York
| $51K | 10,100 | +10,100 | New |
|
|
7
UBS Group
Zurich,
Switzerland
| $2K | 344 | +344 | New |
|
8
Morgan Stanley
New York
| $0 | 2 | -28,147 | -100% |
|
|
9
Bank of Montreal
Toronto,
Ontario, Canada
| – | – | -4,540 | Closed |
|
|
10
JPMorgan Chase & Co
New York
| – | – | -621 | Closed |
|
|
CFGS
11
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|